FDA expands age indication for EVO ICL

Editor’s note: This is a developing news story. Please check back soon for updates.The FDA approved an expanded age indication for the EVO/EVO+ Visian Implantable Collamer Lens in the U.S.Previously approved for patients between the ages of 21 to 45 ye…